Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Letter:</i> Syncope and Contact Urticaria Following Patch Testing to Natural Product Allergens.

Dermatitis : contact, atopic, occupational, drug·2026

Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026

Same author

Reconstitution, Storage, and Infection Outcomes of Botulinum Toxin in Academic Dermatology: A National Survey.

Journal of the American Academy of Dermatology·2026

Same author

Management of Post-Procedure Eruptive Keratoacanthomas: A Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026

Same author

What US Medical Students Need to Learn About Clinical Practice Guidelines: A Qualitative Study of US Students and a Global Subset of Guidelines Developers.

Journal of clinical epidemiology·2026

Same author

Restorative cosmetic dermatology: Utilizing cosmetic procedures to correct appearance and function in patients with medical dermatologic conditions - Part II. Condition-specific applications.

Journal of the American Academy of Dermatology·2026

Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026

Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026

Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026

Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026

Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026

Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 20, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Cutaneous Mesenchymal Sarcomas.

Frances Walocko¹, Rachel E Christensen¹, Brandon Worley²

¹Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 North Saint Clair Street, 1600, Chicago, IL 60611, USA.

Dermatologic Clinics

|November 21, 2022

Summary

This summary is machine-generated.

Cutaneous mesenchymal sarcomas are rare skin cancers lacking clear management guidelines. Aggressive subtypes have higher recurrence and metastasis risks, necessitating further research into targeted therapies.

Keywords:

Cutaneous mesenchymal sarcoma Dermatologic surgery Mohs micrographic surgery Nonmelanoma skin cancer

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Experiment Videos

Last Updated: Aug 20, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Area of Science:

Oncology
Dermatology
Surgical Pathology

Background:

Cutaneous mesenchymal sarcomas are rare skin malignancies.
Includes dermatofibrosarcoma protuberans, atypical fibroxanthoma, pleomorphic dermal sarcoma, cutaneous angiosarcoma, myofibrosarcoma, and leiomyosarcoma.
These tumors lack established staging and management guidelines.

Purpose of the Study:

To review the characteristics and challenges associated with cutaneous mesenchymal sarcomas.
To highlight the need for improved treatment strategies for these rare cancers.

Main Methods:

Literature review of cutaneous mesenchymal sarcomas.
Analysis of treatment outcomes and recurrence rates.
Assessment of metastatic potential and survival data for specific subtypes.

Main Results:

Complete surgical removal is the primary treatment for local disease.
Recurrence rates are higher than for common nonmelanoma skin cancers.
Cutaneous angiosarcoma, pleomorphic dermal sarcoma, and subcutaneous leiomyosarcoma exhibit higher metastatic risk and lower survival.

Conclusions:

Cutaneous mesenchymal sarcomas present significant clinical challenges due to rarity and lack of guidelines.
Aggressive subtypes require specialized attention and further investigation.
Development of targeted therapies is crucial for improving outcomes in advanced cases.